Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia DOI
Tsuyoshi Okada, Hikaru Hori, Naomi Hasegawa

и другие.

Journal of Clinical Psychopharmacology, Год журнала: 2022, Номер 42(6), С. 591 - 593

Опубликована: Окт. 3, 2022

Okada, Tsuyoshi MD, PhD; Hori, Hikaru Hasegawa, Naomi Murata, Atsunobu MS; Kyou, Yoshitaka Kodaka, Fumitoshi Iida, Hitoshi Ochi, Shinichiro Takaesu, Yoshikazu Tsuboi, Takashi Iga, Jun-ichi Ichihashi, Kayo MD; Muraoka, Hiroyuki Furihata, Ryuji Yasui-Furukori, Norio Usami, Masahide Onitsuka, Toshiaki Ogasawara, Kazuyoshi Tagata, Hiromi Takeshima, Masahiro Ohi, Kazutaka Numata, Shusuke Hashimoto, Naoki Yamada, Hiroki Makinodan, Manabu Komatsu, Hiroshi Hishimoto, Akitoyo Yamagata, Hirotaka Kido, Mikio Kubota, Chika Atake, Kiyokazu Hisashi Nagasawa, Tatsuya Matsumoto, Junya Miura, Kenichiro Inada, Ken Watanabe, Koichiro Suda, Shiro Ryota PhD Author Information

Relationships between clinician adherence to guideline-recommended treatment and memory function in patients with schizophrenia DOI Creative Commons
Yasushi Kawamata, Kazutaka Ohi, Satsuki Ito

и другие.

Journal of Psychiatric Research, Год журнала: 2025, Номер 185, С. 169 - 176

Опубликована: Март 29, 2025

Memory function impairment is severe in patients with schizophrenia, but improving memory remains challenging. The use of benzodiazepines and anticholinergics, which are not recommended by pharmacological therapy guidelines for has been associated worsened cognitive function. However, it unclear whether better adherence psychiatrists to schizophrenia improved Therefore, we investigated the relationship between psychiatrists' schizophrenia. To evaluate associations function, utilized Individual Fitness Score (IFS), includes multiple quality indicators, assess each psychiatrist's these treating patient. was measured using Wechsler Scale-Revised a total 351 patients, including 40 treatment-resistant (TRS) 311 non-TRS. We found that psychiatrist significantly positively correlated verbal (β = 0.145, p 6.45 × 10-3), attention/concentration 0.138, 0.010), delayed recall 0.167, 1.57 10-3) all Additionally, nominal positive correlation observed visual 0.124, 0.019). In non-TRS 0.166, 3.17 nominally 0.141, 0.013) 0.114, 0.044) functions. contrast, no significant were any functions TRS. These findings suggest enhancing guideline education might improve impairments

Язык: Английский

Процитировано

0

Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study DOI Creative Commons
Shinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa

и другие.

The International Journal of Neuropsychopharmacology, Год журнала: 2025, Номер 28(4)

Опубликована: Март 28, 2025

The rate of antipsychotic polypharmacy is high. One risk factor for may be the severity schizophrenia, including treatment-resistant schizophrenia (TRS). We hypothesized that institutions are able to prescribe clozapine present differences in pharmacological treatment even before TRS diagnosed. A total 8155 patients with were divided into clozapine-available institution (CAI) group and clozapine-unavailable (CUI) group. psychotropic prescription rates at discharge compared between two groups. Furthermore, investigate whether diagnosis subgroups influenced efficacy, we CAIs CUIs descriptions (DSTRS) those without (NDSTRS). Compared CUI group, both monotherapy (58.3% vs. 50.7%; p = 2.4 × 10-7) concomitant use other psychotropics (20.4% 15.6%; 3.8 10-5) significantly higher CAI DSTRS (63.3%) was than NDSTRS (54.5%; 1.4 10-12), (49.6%; 4.9 10-9), (50.9%; 2.0 10-8). (22.6%) also (18.7%; 4.7 10-4), (15.9%; 5.5 (15.2%; 8.0 10-5). There no significant difference these Both availability prescriptions precise can promote development an organizational culture facilitates schizophrenia.

Язык: Английский

Процитировано

0

Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study DOI Creative Commons
Shinichiro Ochi,

Hiromi Tagata,

Naomi Hasegawa

и другие.

The International Journal of Neuropsychopharmacology, Год журнала: 2022, Номер 25(10), С. 818 - 826

Опубликована: Июнь 20, 2022

Abstract Background Although clozapine is effective for treatment-resistant schizophrenia (TRS), the rate of prescription still low. Whereas antipsychotic monotherapy recommended in clinical practice guidelines, polypharmacy high. There little evidence on whether a influences changes and polypharmacy, including antipsychotics other psychotropics. We therefore hypothesized that patients with TRS who were prescribed would be higher than not clozapine. Methods assessed 8306 nationwide from 178 institutions Japan 2016 to 2019. analyzed psychotropic data at discharge diagnosed no description (ND-TRS) based diagnosis listed summary. Results The group (91.3%) was significantly without (45.9%; P < 2.0 × 10−16) ND-TRS (54.7%; 10−16). any concomitant psychotropics (26.5%) (12.6%; = 1.1 10−6) (17.0%; 5.9 10−6). Conclusions Clozapine could associated high monotherapy. Patients will benefit correct thus proper prescription.

Язык: Английский

Процитировано

18

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study DOI

Norio Yasui‐Furukori,

Hiroyuki Muraoka, Naomi Hasegawa

и другие.

Neuropsychopharmacology Reports, Год журнала: 2021, Номер 42(1), С. 3 - 9

Опубликована: Дек. 2, 2021

Abstract Background The decision to initiate clozapine treatment should be made on an individual basis and may closely related the early detection of treatment‐resistant schizophrenia (TRS), although there is evidence that use results in a better response treatment. Therefore, we investigated relationship between examination rate TRS prescription clozapine. Methods After attending 1‐day educational program based "Guidelines for Pharmacological Treatment Schizophrenia," asked participating facilities submit records whether or not was evaluated each patient. We calculated from schizophrenic patients prescribed all patients. Forty‐nine 2017 were included study. Results There dichotomous distributions non‐normal distribution significant correlation ( r s = 0.531, P 1.032 × 10 −4 ). A difference found three groups according TRS. Conclusion As preliminary problem clozapine, Japan, varies, are many typically do consider possibility TRS; this trend leads low use. Clearly, further clinician training needed appropriate management includes explanation how introduce therapy their families.

Язык: Английский

Процитировано

21

Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study DOI Creative Commons
Ryuji Furihata,

Rei Otsuki,

Naomi Hasegawa

и другие.

Sleep Medicine, Год журнала: 2021, Номер 89, С. 23 - 30

Опубликована: Ноя. 22, 2021

Язык: Английский

Процитировано

21

A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project DOI Creative Commons
Hisashi Yamada,

Mikuni Motoyama,

Naomi Hasegawa

и другие.

BJPsych Open, Год журнала: 2022, Номер 8(3)

Опубликована: Апрель 21, 2022

Clinical practice guidelines for schizophrenia and major depressive disorder have been published. However, these not had sufficient penetration in clinical settings. We developed the Effectiveness of Guidelines Dissemination Education Psychiatric Treatment (EGUIDE) project as a dissemination education programme psychiatrists.The aim this study is to assess effectiveness EGUIDE on subjective behaviour psychiatrists accordance with before 1 2 years after participation programmes.A total 607 participated during October 2016 March 2019. They attended both 1-day educational programmes based disorder, answered web questionnaires about their behaviours attending programmes. evaluated changes between programme.All scores were significantly improved compared There no significant any attending.All programme, maintained at least years. The could contribute guideline-based among psychiatrists.

Язык: Английский

Процитировано

16

The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project DOI
Kayo Ichihashi,

Yoshitaka Kyou,

Naomi Hasegawa

и другие.

Asian Journal of Psychiatry, Год журнала: 2022, Номер 69, С. 103007 - 103007

Опубликована: Янв. 13, 2022

Язык: Английский

Процитировано

15

Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study DOI Creative Commons
Naomi Hasegawa, Yuka Yasuda,

Norio Yasui‐Furukori

и другие.

Psychiatry and Clinical Neurosciences, Год журнала: 2023, Номер 77(10), С. 559 - 568

Опубликована: Сен. 8, 2023

This study aims to examine the real-world effectiveness of education regarding clinical guidelines for psychiatric disorders using 'the Effectiveness dissemination and in treatment (EGUIDE)' project.

Язык: Английский

Процитировано

8

Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry DOI
Kazuyoshi Ogasawara, Shusuke Numata, Naomi Hasegawa

и другие.

Neuropsychopharmacology Reports, Год журнала: 2022, Номер 42(2), С. 221 - 225

Опубликована: Март 10, 2022

Abstract The Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE) project, which is a nationwide dissemination implementation program clinical practice guidelines (CPGs) the field psychiatry, currently ongoing. In current study, subjective assessment participants EGUIDE programs was assessed using questionnaire. Then, relationships between assessment, characteristics participants, knowledge CPGs were evaluated. More than 90% gave high rating components content, recommendation, knowledge, skill, adherence, but not component confidence. A positive correlation found years professional experience score These results suggest that it may be necessary to apply skills obtained education into increase confidence proper use therapies based on CPGs.

Язык: Английский

Процитировано

14

Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone DOI Creative Commons
Regina Taurines, Stefanie Fekete,

A. Preuss-Wiedenhoff

и другие.

Journal of Neural Transmission, Год журнала: 2022, Номер 129(5-6), С. 689 - 701

Опубликована: Март 18, 2022

Abstract Risperidone is commonly used to treat different psychiatric disorders worldwide. Knowledge on dose–concentration relationships of risperidone treatment in children and adolescents with schizophrenia or other psychotic is, however, scarce no age-specific therapeutic ranges have been established yet. Multicenter data a drug monitoring service were analyzed evaluate the relationship between dose serum concentration active moiety (risperidone (RIS) plus its main metabolite 9-hydroxyrisperidone (9-OH-RIS)) disorders. Patient characteristics, doses, concentrations outcomes assessed by standardized measures. The study also aimed whether reference range for adults (20–60 ng/ml) applicable minors. In 64 patients (aged 11–18 years) included, positive correlation daily (RIS am ) was found ( r s = 0.49, p 0.001) variation explaining 24% 2 0.240) variability concentrations. While RIS showed difference, as well 9-OH-RIS parent ratio varied significantly co-medication CYP2D6 inhibitor. Patients extrapyramidal symptoms (EPS) had average higher RISam than without 0.05). Considering EPS, upper threshold determined be 33 ng/ml. A rough estimation method indicated possibly decreased lower limit preliminary minors compared adults. These may contribute definition window schizophrenic treated risperidone. TDM recommended this vulnerable population prevent concentration-related adverse reactions.

Язык: Английский

Процитировано

13